Haploidentical hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen which consist rituximab and mesencymal stem cell infusion in children; preliminary results

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAtay, D.
dc.contributor.authorErbey, F.
dc.contributor.authorAkcay, A.
dc.contributor.authorAkbiyik, M.
dc.contributor.authorHarman, O.
dc.contributor.authorOvali, E.
dc.contributor.authorOzturk, G.
dc.date.accessioned2025-10-16T15:31:32Z
dc.date.issued2015
dc.description.abstract41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Istanbul, TURKEY, MAR 22-25, 2015
dc.identifier.otherWOS:000351632901211
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9033
dc.publisherNATURE PUBLISHING GROUP
dc.sourceBONE MARROW TRANSPLANTATION
dc.titleHaploidentical hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen which consist rituximab and mesencymal stem cell infusion in children; preliminary results
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS